Evidence map›Paper›PMID 27053324›Full record

ArticleACS combinatorial science2016

Rapid Discovery of Functional Small Molecule Ligands against Proteomic Targets through Library-Against-Library Screening.

Chun-Yi Wu, Don-Hong Wang, Xiaobing Wang, Seth M Dixon, Liping Meng, Sara Ahadi, Daniel H Enter, Chao-Yu Chen, Jason Kato, Leonardo J Leon and 7 more

Abstract read
In one paragraph

Article in ACS combinatorial science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. My Perspective on OBOC Combinatorial Technology.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Chun-Yi WuDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Don-Hong WangDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Xiaobing WangDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Seth M DixonDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Liping MengDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Sara AhadiDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Daniel H EnterDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Chao-Yu ChenDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Jason KatoPharmacology and Toxicology Graduate Group, University of California, Davis , Davis, California 95616, United States.
Leonardo J LeonPharmacology and Toxicology Graduate Group, University of California, Davis , Davis, California 95616, United States.
Laura M RamirezDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Yoshiko MaedaDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Carolina F ReisDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Brianna RibeiroDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Brittany WeemsDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Hsing-Jien KungDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
Kit S LamDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine , 2700 Stockton Boulevard, Suite 2102, Sacramento, California 95817, United States.
University of California, Davis · USNational Health Research Institutes · TW

Funding

Discovery of Death Ligands Against CancersR33CA160132 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LAM, KIT S · 2012 to 2014
$1.0M
NCI NIH HHS R33 CA160132
6 · The paper itself

Abstract

Identifying "druggable" targets and their corresponding therapeutic agents are two fundamental challenges in drug discovery research. The one-bead-one-compound (OBOC) combinatorial library method has been developed to discover peptides or small molecules that bind to a specific target protein or elicit a specific cellular response. The phage display cDNA expression proteome library method has been employed to identify target proteins that interact with specific compounds. Here, we combined these two high-throughput approaches, efficiently interrogated approximately 10(13) possible molecular interactions, and identified 91 small molecule compound beads that interacted strongly with the phage library. Of 19 compounds resynthesized, 4 were cytotoxic against cancer cells; one of these compounds was found to interact with EIF5B and inhibit protein translation. As more binding pairs are confirmed and evaluated, the "library-against-library" screening approach and the resulting small molecule-protein domain interaction database may serve as a valuable tool for basic research and drug development.

Indexed as

Peptide LibrarySmall Molecule LibrariesAntineoplastic AgentsBenzimidazolesCell CycleCell LineCombinatorial Chemistry TechniquesDNA, ComplementaryDrug DiscoveryDrug Screening Assays, AntitumorHigh-Throughput Screening AssaysHumansJurkat CellsLigandsMethionineProteomicsAntineoplastic AgentsBenzimidazolesDNA, ComplementaryLigandsMethioninePeptide LibrarySmall Molecule Librarieslibrary-against-library screeningmolecular interactionsone-bead-one-compound combinatorial libraryphage display cDNA expression proteome librarysmall molecule compound beads

Identifiers

PMID27053324
PMCPMC4908505
OpenAlexW2332075901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.